Vantage Point

Our latest thinking on biopharmaceutical development and commercialization.

Rick Turner

Medical Device Treatment for Resistant Hypertension
Rick Turner explains the rationale for a much-needed, new approach to treating hypertension.

Quintiles Blog

Fresh ideas and insights from our experts around the globe


Topics to Explore

Evidence & Value

Healthcare costs are climbing, regulators around the globe are requiring more information, and both providers and payers have higher expectations for a medical treatment’s proof of value before prescribing or paying for those treatments.


As the prevalence of diabetes continues to increase globally, and the market for new therapies grows increasingly crowded, it's more important than ever to match the right drug to the right patient.

Data & Technology

To turn data into insights, upgraded IT systems are essential. Outdated systems lead to significant costs – in terms of time, frustration and an increased risk of errors. Integrated IT systems are a crucial component in reducing manual processes, resulting in fewer errors, faster processes, far less frustration and ultimately lowering your costs. Benefit from more insightful data analysis, which can lead to groundbreaking discoveries.

Rare Diseases

3+ years looking for treatment

Although regulatory incentives and the designation of “orphan” products have stimulated commercial research for rare diseases, their low prevalence, high complexity and predominance in children create significant barriers. Providers and patients are clamoring for treatment access and improved outcomes, but increasingly payers are making hard choices about reimbursing these therapies.


Biosimilar development and commercialization is a uniquely difficult endeavor requiring precise, stepwise planning to ensure timely regulatory approval and optimal market access. 

Peer-Reviewed Publications
Tradeoff-based optimization criteria in clinical trials with multiple objectives and adaptive designs.
J Biopharm Stat. 2015 Sep 21.
Read more
Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
Value Health. 2015 Sep;18(6):817-23.
Read more
Practical designs for phase I combination studies in oncology.
J Biopharm Stat. 2015 Sep 17.
Read more
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.
AAPS J. 2015 Sep 16.
Read more
Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda.
J Rheumatol. 2015 Sep 15. pii: jrheum.141423.
Read more